Alerts will be sent to your verified email
Verify EmailADESHWAR
|
Adeshwar Meditex
|
Ishita Drugs & Inds.
|
Venmax Drugs&Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.67 % | 8.38 % | -46.46 % |
|
5yr average Equity Multiplier
|
2.23 | 1.27 | 0.08 |
|
5yr Average Asset Turnover Ratio
|
1.12 | 1.23 | 0.14 |
|
5yr Avg Net Profit Margin
|
2.25 % | 5.43 % | -19.62 % |
|
Price to Book
|
0.65 | 2.05 | 2.33 |
|
P/E
|
11.56 | 23.41 | 59.34 |
|
5yr Avg Cash Conversion Cycle
|
157.84 Days | 74.52 Days | 288.55 Days |
|
Inventory Days
|
119.5 Days | 35.08 Days | 5.2 Days |
|
Days Receivable
|
131.36 Days | 31.6 Days | 430.69 Days |
|
Days Payable
|
99.91 Days | 42.7 Days | 141.12 Days |
|
5yr Average Interest Coverage Ratio
|
2.29 | 24.46 | -260.56 |
|
5yr Avg ROCE
|
12.9 % | 11.48 % | -47.43 % |
|
5yr Avg Operating Profit Margin
|
6.1 % | 6.66 % | -65.91 % |
|
5 yr average Debt to Equity
|
0.59 | 0.09 | -0.45 |
|
5yr CAGR Net Profit
|
4.26 % | 0.95 % | -42.57 % |
|
5yr Average Return on Assets
|
2.58 % | 6.68 % | 199.45 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.55 % | 49.96 % | 23.13 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.9 % | 0.64 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Adeshwar Meditex
|
Ishita Drugs & Inds.
|
Venmax Drugs&Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|